Dihexa: Rewiring the Brain

About this episode

The episode discusses Dihexa, a synthetic peptide that may rewire the brain but lacks human clinical trial data.

Dihexa is a synthetic peptide developed at Washington State University that has gained significant attention in the biohacking community for its potential to physically rewire the brain . Unlike traditional nootropics that focus on neurotransmitter levels, this compound appears to encourage synaptogenesis , or the creation of new neural connections, by enhancing HGF/c-Met signaling . While animal studies and laboratory models have shown remarkable results in treating cognitive decline and brain injury , there is a complete lack of human clinical trial data regarding its safety or effectiveness. This absence of formal research leaves critical questions unanswered about optimal dosing and long-term risks, including a theoretical concern regarding tumor promotion . Consequently, the substance remains a controversial topic, defined by a sharp divide between mythologized online anecdotes and a lack of verified medical evidence.

Topics covered

• synthetic peptides
• biohacking
• cognitive enhancement
• neural connections
• brain injury
• clinical trials

Keywords

• Dihexa
• synthetic peptide
• biohacking
• cognitive decline
• brain injury
• synaptogenesis
• HGF/c-Met
• clinical trials

Mentioned in this episode

Organizations: Washington State University

Products: Dihexa, HGF/c-Met

More episodes of Today's discussion

• Pinealon: The Science and Hype of Brain Bioregulators · September 8, 2026 · 21 min
• Dulaglutide: The Foundation of Modern Metabolic Medicine · August 31, 2026 · 21 min
• FOXO4-DRI: The Science and Hype of Senolytic Peptides · August 24, 2026 · 26 min
• Cerebrolysin: Clinical Science and Biohacking Analysis · August 17, 2026 · 23 min
• ADAMAX Peptide: Science, Hype, and Cognitive Potential · August 10, 2026 · 19 min
• Survodutide: The Metabolic Power of Dual Receptor Agonism · August 3, 2026 · 20 min